Julia Katharina Tietze, MD
Julia Katharina Tietze, MD
University Augsburg, University Munich, LMU
Verified email at med.uni-muenchen.de
TitleCited byYear
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
L Hofmann, A Forschner, C Loquai, SM Goldinger, L Zimmer, S Ugurel, ...
European journal of cancer 60, 190-209, 2016
2922016
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
L Zimmer, SM Goldinger, L Hofmann, C Loquai, S Ugurel, I Thomas, ...
European journal of cancer 60, 210-225, 2016
2462016
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions
JC Hassel, L Heinzerling, J Aberle, O Bähr, TK Eigentler, MO Grimm, ...
Cancer treatment reviews 57, 36-49, 2017
842017
Characterization of mouse CD4 T cell subsets defined by expression of KLRG1
N Beyersdorf, X Ding, JK Tietze, T Hanke
European journal of immunology 37 (12), 3445-3454, 2007
652007
Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy
JK Tietze, DEC Wilkins, GD Sckisel, MN Bouchlaka, KL Alderson, ...
Blood 119 (13), 3073-3083, 2012
522012
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
MV Heppt, L Heinzerling, KC Kähler, A Forschner, MC Kirchberger, ...
European Journal of Cancer 82, 56-65, 2017
382017
Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab–A report of 29 patients
K Katzer, J Tietze, E Klein, V Heinemann, T Ruzicka, A Wollenberg
European Journal of Dermatology 20 (1), 82-84, 2010
342010
CTLA4 as immunological checkpoint in the development of multiple sclerosis
LA Gerdes, K Held, E Beltrán, C Berking, JC Prinz, A Junker, JK Tietze, ...
Annals of neurology 80 (2), 294-300, 2016
292016
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma
MV Heppt, A Roesch, B Weide, R Gutzmer, F Meier, C Loquai, KC Kähler, ...
European Journal of Cancer 81, 36-44, 2017
242017
Influenza infection results in local expansion of memory CD8+ T cells with antigen non‐specific phenotype and function
GD Sckisel, JK Tietze, AE Zamora, HH Hsiao, SO Priest, DEC Wilkins, ...
Clinical & Experimental Immunology 175 (1), 79-91, 2014
242014
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis
MV Heppt, TK Eigentler, KC Kähler, RA Herbst, D Göppner, T Gambichler, ...
Cancer Immunology, Immunotherapy 65 (8), 951-959, 2016
232016
Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients
JK Tietze, MV Heppt, A von Preußen, U Wolf, T Ruzicka, H Wolff, ...
Journal of the European Academy of Dermatology and Venereology 29 (9), 1816-1821, 2015
222015
Linear and volumetric evaluation of the adrenal gland—MDCT-based measurements of the adrenals
J Schneller, M Reiser, F Beuschlein, A Osswald, A Pallauf, A Riester, ...
Academic radiology 21 (11), 1465-1474, 2014
222014
Rosazea
K Gauwerky, W Klövekorn, HC Korting, P Lehmann, EM Meigel, D Reinel, ...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft 7 (11), 996-1003, 2009
212009
The proportion of circulating CD45RO+ CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab
JK Tietze, D Angelova, MV Heppt, M Reinholz, WJ Murphy, M Spannagl, ...
European Journal of Cancer 75, 268-279, 2017
192017
Combination therapy of melanoma using kinase inhibitors
MV Heppt, JK Tietze, SA Graf, C Berking
Current opinion in oncology 27 (2), 134-140, 2015
142015
High-definition optical coherence tomography in the diagnosis of basal cell carcinoma evaluated by an experienced versus inexperienced investigator
G Li, J Tietze, D Kulichova, T Ruzicka, C Berking, T Maier
J Clin Exp Dermatol Res 5 (4), 2014
112014
Morphologic features of basal cell carcinoma using the en‐face mode in frequency domain optical coherence tomography
T von Braunmühl, D Hartmann, JK Tietze, D Cekovic, C Kunte, T Ruzicka, ...
Journal of the European Academy of Dermatology and Venereology 30 (11), 1919 …, 2016
102016
The systemic management of advanced melanoma in 2016
MV Heppt, C Dietrich, SA Graf, T Ruzicka, JK Tietze, C Berking
Oncology research and treatment 39 (10), 635-642, 2016
102016
Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help
AM Monjazeb, JK Tietze, SK Grossenbacher, HH Hsiao, AE Zamora, ...
PloS one 9 (8), e102709, 2014
102014
The system can't perform the operation now. Try again later.
Articles 1–20